7. Concluding Remarks
The discovery that TLR9 can promote the production of autoantibodies by synergistically activating B cells in conjunction with BCR raises the intriguing possibility that self-DNA is immunostimulatory in a T cell-independent manner. Furthermore, TLRs can no longer be regarded as recognition systems in the innate immune system that shows exclusive selectivity for pathogen-associated molecules. TLR9 compromises the capacity for absolute distinction between self and nonself. Our current molecular appreciation of the TLR9 signaling pathway provides hope for therapeutic manipulation and the design of novel strategies for treating autoimmune diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahmad-Nejad, P., Hacker, H., Rutz, M., Bauer, S., Vabulas, R.M., and Wagner, H. (2002). Bacterial CpG-DNA and lipopolysaccharides activate toll-like receptors at distinct cellular compartments. Eur. J. Immunol., 32, 1958–1968.
Alexopoulou, L., Holt, A.C., Medzhitov, R., and Flavell, R.A. (2001). Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3. Nature, 413, 732–738.
Aliprantis, A.O., Yang, R.B., Mark, M.R., Suggett, S., Devaux, B., Radolf, J.D., Klimpel, G.R., Godowski, P., and Zychlinsky, A. (1999). Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science, 285, 736–739.
Bauer, S., Kirschning, C.J., Hacker, H., Redecke, V., Hausmann, S., Akira, S., Wagner, H., and Lipford, G.B. (2001). Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. USA, 98, 9237–9242.
Bird, A.P. (1987). CpG islands as gene markers in the vertebrate nucleus. Trends Genet., 3, 342–347.
Boone, D.L., Turer, E.E., Lee, E.G., Ahmad, R.C., Wheeler, M.T., Tsui, C., Hurley, P., Chien, M., Chai, S., Hitotsumatsu, O., McNally, E., Pickart, C., and Ma, A. (2004). The ubiquitin-modifying enzyme A20 is required for termination of toll-like receptor responses. Nat. Immunol., 5, 1052–1060.
Bourke, E., Kennedy, E.J., and Moynagh, P.N. (2000). Loss of Ikappa B-beta is associated with prolonged NF-kappa B activity in human glial cells. J. Biol. Chem., 275, 39996–40002.
Brady, K., Fitzgerald, S., Ingvarsson, S., Borrebaeck, C.A., and Moynagh, P.N. (2001). CD40 employs p38 MAP kinase in IgE isotype switching. Biochem. Biophys. Res. Commun., 289, 276–281.
Brady, K., Fitzgerald, S., and Moynagh, P.N. (2000). Tumour-necrosis-factor-receptor-associated factor 6, NF-kappaB-inducing kinase and IkappaB kinases mediate IgE isotype switching in response to CD40. Biochem. J., 350, 735–740.
Burns, K., Clatworthy, J., Martin, L., Martinon, F., Plumpton, C., Maschera, B., Lewis, A., Ray, K., Tschopp, J., and Volpe, F. (2000). Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat. Cell Biol., 2, 346–351.
Cao, Z., Henzel, W.J., and Gao, X. (1996). IRAK: A kinase associated with the interleukin-1 receptor. Science, 271, 1128–1131.
Chow, J.C., Young, D.W., Golenbock, D.T., Christ, W.J., and Gusovsky, F. (1999). Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem., 274, 10689–10692.
Chu, W., Gong, X., Li, Z., Takabayashi, K., Ouyang, H., Chen, Y., Lois, A., Chen, D.J., Li, G.C., Karin, M., and Raz, E. (2000). DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA. Cell, 103, 909–918.
Diebold, S.S., Kaisho, T., Hemmi, H., Akira, S., and Reis e Sousa, C. (2004). Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science, 303, 1529–1531.
Goeckeritz, B.E., Flora, M., Witherspoon, K., Vos, Q., Lees, A., Dennis, G.J., Pisetsky, D.S., Klinman, D.M., Snapper, C.M., and Mond, J.J. (1999). Multivalent cross-linking of membrane Ig sensitizes murine B cells to a broader spectrum of CpG-containing oligodeoxynucleotide motifs, including their methylated counterparts, for stimulation of proliferation and Ig secretion. Int. Immunol., 11, 1693–1700.
Gon, Y., Asai, Y., Hashimoto, S., Mizumura, K., Jibiki, I., Machino, T., Ra, C., and Horie, T. (2004). A20 inhibits toll-like receptor 2-and 4-mediated interleukin-8 synthesis in airway epithelial cells. Am. J. Respir. Cell Mol. Biol., 31, 330–336.
Hacker, H., Mischak, H., Miethke, T., Liptay, S., Schmid, R., Sparwasser, T., Heeg, K., Lipford, G.B., and Wagner, H. (1998). CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J., 17, 6230–6240.
Hartmann, G., Weiner, G.J., and Krieg, A.M. (1999). CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells. Proc. Natl. Acad. Sci. USA, 96, 9305–9310.
Hayashi, F., Smith, K.D., Ozinsky, A., Hawn, T.R., Yi, E.C., Goodlett, D.R., Eng, J.K., Akira, S., Underhill, D.M., and Aderem, A. (2001). The innate immune response to bacterial flagellin is mediated by toll-like receptor 5. Nature, 410, 1099–1103.
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., and Bauer, S. (2004). Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science, 303, 1526–1529.
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., and Akira, S. (2000). A toll-like receptor recognizes bacterial DNA. Nature, 408, 740–745.
Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K., and Akira, S. (1999). Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product. J. Immunol., 162, 3749–3752.
Janssens, S., Burns, K., Vercammen, E., Tschopp, J., and Beyaert, R. (2003). MyD88S, a splice variant of MyD88, differentially modulates NF-kappaB-and AP-1-dependent gene expression. FEBS Lett., 548, 103–107.
Kobayashi, K., Hernandez, L.D., Galan, J.E., Janeway, C.A., Jr., Medzhitov, R., and Flavell, R.A. (2002). IRAK-M is a negative regulator of toll-like receptor signaling. Cell, 110, 191–202.
Krieg, A.M. (2002). A role for toll in autoimmunity. Nat. Immunol., 3, 423–424.
Krieg, A.M., Yi, A.K., Matson, S., Waldschmidt, T.J., Bishop, G.A., Teasdale, R., Koretzky, G.A., and Klinman, D.M. (1995). CpG motifs in bacterial DNA trigger direct B-cell activation. Nature, 374, 546–549.
Krug, A., Towarowski, A., Britsch, S., Rothenfusser, S., Hornung, V., Bals, R., Giese, T., Engelmann, H., Endres, S., Krieg, A.M., and Hartmann, G. (2001). Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol., 31, 3026–3037.
Leadbetter, E.A., Rifkin, I.R., Hohlbaum, A.M., Beaudette, B.C., Shlomchik, M.J., and Marshak-Rothstein, A. (2002). Chromatin-IgG complexes activate B cells by dual engagement of IgM and toll-like receptors. Nature, 416, 603–607.
Li, L., Cousart, S., Hu, J., and McCall, C.E. (2000). Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells. J. Biol. Chem., 275, 23340–23345.
Li, S., Strelow, A., Fontana, E.J., and Wesche, H. (2002). IRAK-4: A novel member of the IRAK family with the properties of an IRAK-kinase. Proc. Natl. Acad. Sci. USA, 99, 5567–5572.
Li, X., Commane, M., Burns, C., Vithalani, K., Cao, Z., and Stark, G.R. (1999). Mutant cells that do not respond to interleukin-1 (IL-1) reveal a novel role for IL-1 receptor-associated kinase. Mol. Cell. Biol., 19, 4643–4652.
Medzhitov, R., Preston-Hurlburt, P., and Janeway, C.A., Jr. (1997). A human homologue of the Drosophila toll protein signals activation of adaptive immunity. Nature, 388, 394–397.
Medzhitov, R., Preston-Hurlburt, P., Kopp, E., Stadlen, A., Chen, C., Ghosh, S., and Janeway, C.A., Jr. (1998). MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell, 2, 253–258.
Muzio, M., Ni, J., Feng, P., and Dixit, V.M. (1997). IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science, 278, 1612–1615.
Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J., Cao, Z., and Matsumoto, K. (1999). The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signaling pathway. Nature, 398, 252–256.
O’Neill, L.A. (2002). Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily. Curr. Top. Microbiol. Immunol., 270, 47–61.
O’Reilly, S.M. and Moynagh, P.N. (2003). Regulation of toll-like receptor 4 signaling by A20 zinc finger protein. Biochem. Biophys. Res. Commun., 303, 586–593.
Ozinsky, A., Underhill, D.M., Fontenot, J.D., Hajjar, A.M., Smith, K.D., Wilson, C.B., Schroeder, L., and Aderem, A. (2000). The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. USA, 97, 13766–13771.
Poltorak, A., He, X., Smirnova, I., Liu, M.Y., Van Huffel, C., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., Freudenberg, M., Ricciardi-Castagnoli, P., Layton, B., and Beutler, B. (1998). Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science, 282, 2085–2088.
Qureshi, S.T., Lariviere, L., Leveque, G., Clermont, S., Moore, K.J., Gros, P., and Malo, D. (1999). Endotoxin-tolerant mice have mutations in toll-like receptor 4 (Tlr4). J. Exp. Med., 189, 615–625.
Richardson, B., Scheinbart, L., Strahler, J., Gross, L., Hanash, S., and Johnson, M. (1990). Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheumatol., 33, 1665–1673.
Rui, L., Vinuesa, C.G., Blasioli, J., and Goodnow, C.C. (2003). Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling. Nat. Immunol., 4, 594–600.
Suzuki, N., Suzuki, S., Duncan, G.S., Millar, D.G., Wada, T., Mirtsos, C., Takada, H., Wakeham, A., Itie, A., Li, S., Penninger, J.M., Wesche, H., Ohashi, P.S., Mak, T.W., and Yeh, W.C. (2002). Severe impairment of interleukin-1 and toll-like receptor signaling in mice lacking IRAK-4. Nature, 416, 750–756.
Takeshita, F., Leifer, C.A., Gursel, I., Ishii, K.J., Takeshita, S., Gursel, M., and Klinman, D.M. (2001). Cutting edge: Role of toll-like receptor 9 in CpG DNA-induced activation of human cells. J. Immunol., 167, 3555–3558.
Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K., and Akira, S. (1999). Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity, 11, 443–451.
Viglianti, G.A., Lau, C.M., Hanley, T.M., Miko, B.A., Shlomchik, M.J., and Marshak-Rothstein, A. (2003). Activation of autoreactive B cells by CpG dsDNA. Immunity, 19, 837–847.
Wald, D., Qin, J., Zhao, Z., Qian, Y., Naramura, M., Tian, L., Towne, J., Sims, J.E., Stark, G.R., and Li, X. (2003). SIGIRR, a negative regulator of toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol., 4, 920–927.
Wang, H. and Shlomchik, M.J. (1999). Autoantigen-specific B cell activation in Fas-deficient rheumatoid factor immunoglobulin transgenic mice. J. Exp. Med., 190, 639–649.
Wesche, H., Henzel, W.J., Shillinglaw, W., Li, S., and Cao, Z. (1997). MyD88: An adapter that recruits IRAK to the IL-1 receptor complex. Immunity, 7, 837–847.
Yamin, T.T. and Miller, D.K. (1997). The interleukin-1 receptor-associated kinase is degraded by proteosomes following its phosphorylation. J. Biol. Chem., 272, 21540–21547.
Yi, A.K., Chang, M., Peckham, D.W., Krieg, A.M., and Ashman, R.F. (1998a). CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J. Immunol., 160, 5898–5906.
Yi, A.K. and Krieg, A.M. (1998a). CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of I kappa B alpha and I kappa B beta and sustained activation of nuclear factor-kappa B/c-Rel. J. Immunol., 160, 1240–1245.
Yi, A.K. and Krieg, A.M. (1998b). Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA. J. Immunol., 161, 4493–4497.
Yi, A.K., Peckham, D.W., Ashman, R.F., and Krieg, A.M. (1999). CpG DNA rescues B cells from apoptosis by activating NFkappaB and preventing mitochondrial membrane potential disruption via a chloroquine-sensitive pathway. Int. Immunol., 11, 2015–2024.
Yi, A.K., Tuetken, R., Redford, T., Waldschmidt, M., Kirsch, J., and Krieg, A.M. (1998b). CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species. J. Immunol., 160, 4755–4761.
Yi, A.K., Yoon, J.G., and Krieg, A.M. (2003). Convergence of CpG DNA-and BCR-mediated signals at the c-jun-N-terminal kinase and NF-kB activation pathways; regulation by mitogen-activated protein kinases. Int. Immunol., 15, 577–591.
Yung, R.L., Quddus, J., Chrisp, C.E., Johnson, K.J., and Richardson, B.C. (1995). Mechanism of drug-induced lupus. I. Cloned T 2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J. Immunol., 154, 3025–3035.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Moynagh, P.N. (2005). Toll-like Receptor 9 and Autoimmunity. In: Zouali, M. (eds) Molecular Autoimmunity. Springer, Boston, MA. https://doi.org/10.1007/0-387-24534-0_2
Download citation
DOI: https://doi.org/10.1007/0-387-24534-0_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-24533-1
Online ISBN: 978-0-387-24534-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)